Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Panacea Biotec Q4 FY26 Results: Net Loss of ₹1 Cr, Loss Narrows

Panacea Biotec Ltd reported revenue from operations of ₹166.8 Cr (+25.9% YoY) and a net loss of ₹1 Cr for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations166.8165.2132.5
Other income2.52.38.6
Total income169.3167.5141.1
Profit before exceptional items & tax-4.03.7-27.8
Exceptional items2.72.827.7
Profit before tax-1.26.5-0.0
Net profit-1.03.9-2.0
Operating margin-0.7%3.9%0.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Revenue, year on year+25.90%
Source

BSE results filing, NSE: PANACEABIO. Figures extracted from the filing.

Read the filing ↗

Panacea Biotec Ltd: key numbers

Share price
₹372.60
Market cap
₹2,282 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.37 Cr
P/E (TTM)
-320.5×Sector 50.4×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Panacea Biotec Ltd

All →
17:28 IST BSE
Legal & Regulatory

Panacea Biotec Legal & Regulatory

Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.

Value
₹9.82 Cr
15:01 IST BSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.

18:30 IST NSE
Annual General Meeting

Panacea Biotec Annual General Meeting

Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.

17:40 IST NSE
Other Announcement

Panacea Biotec Other Announcement

Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).